iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Cetera Investment Advisers

Cetera Investment Advisers cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 62,921 shares of the financial services provider’s stock after selling 2,384 shares during the quarter. Cetera Investment Advisers owned approximately 0.14% of iShares Biotechnology ETF worth $8,048,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Bank of America Corp DE boosted its stake in shares of iShares Biotechnology ETF by 6.5% during the 4th quarter. Bank of America Corp DE now owns 7,489,427 shares of the financial services provider’s stock worth $990,177,000 after purchasing an additional 460,154 shares during the last quarter. Focus Partners Wealth lifted its stake in shares of iShares Biotechnology ETF by 168.2% during the fourth quarter. Focus Partners Wealth now owns 121,996 shares of the financial services provider’s stock valued at $16,485,000 after buying an additional 76,509 shares during the period. Madrona Financial Services LLC boosted its position in iShares Biotechnology ETF by 153.0% during the first quarter. Madrona Financial Services LLC now owns 81,150 shares of the financial services provider’s stock worth $10,379,000 after acquiring an additional 49,075 shares during the last quarter. GAMMA Investing LLC grew its stake in iShares Biotechnology ETF by 12,698.7% in the 1st quarter. GAMMA Investing LLC now owns 48,251 shares of the financial services provider’s stock worth $6,171,000 after acquiring an additional 47,874 shares during the period. Finally, GTS Securities LLC raised its holdings in iShares Biotechnology ETF by 3,266.0% in the 4th quarter. GTS Securities LLC now owns 46,720 shares of the financial services provider’s stock valued at $6,175,000 after acquiring an additional 45,332 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $132.76 on Friday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.57. The business’s fifty day moving average is $128.36 and its two-hundred day moving average is $128.98.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.